Navigation Links
Platinum Coils To Replace Brain Surgery

Surgeons, in a study published in The Lancet, have proposed treating burst aneurysms with platinum coils instead of brain surgery.

In 2002 the International Subarachnoid Aneurysm Trial (ISAT) was stopped early because it showed that the minimally invasive technique, coiling, was more likely to result in survival without disability at one year when compared to neurosurgical clipping. // The traditional neurosurgical treatment involves a craniotomy and clipping of the aneurysm to stop further bleeding. The coiling treatment is performed by way of a tiny puncture wound in the groin and through the blood vessels.

At the time of the first report the 1-year follow-up data was available for only 1594 of the 2143 patients enrolled and long-term follow up was not available. Now the researchers report the complete 1-year data and results of long-term follow-up.

Researchers from University of Oxford had recruited 2143 patients from 42 neuro-surgical centers in Europe, North America, and Australia. The investigators found that 250 of 1063 (23·5%) patients allocated to endovascular coiling treatment were dead or dependent at one year compared with 326 of 1055 (30·9%) patients allocated to neuro-surgery and clipping. The researchers found that the early survival advantage was maintained up to 7 years. They also found that the risk of late rebleeding was low but more common after endovascular coiling than after neurosurgical clipping. Patients assigned coiling also had a substantially lower risk of seizures than patients allocated to clipping.

According to the researchers, the complete 1-year data from ISAT confirm and reinforce our preliminary findings. Minimally invasive endovascular coil treatment of ruptured brain aneurysms, when a patient is in good clinical condition and the aneurysm is suitable for coiling, is more likely to lead to independent survival at 1 year than neurosurgical clipping.

Source: Newswise, The Lancet
'"/>




Related medicine news :

1. Platinum for the Eye: A new facial palsy implant
2. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
3. Indian Prime Minister has successful Knee Replacement Surgery
4. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
5. Possible benefits of Hormone Replacement Therapy
6. Teens Misusing Nicotine-Replacement Products
7. Hormone Replacement Therapy -- What to do?
8. Testosterone Replacement Therapy Safe If Monitored Appropriately
9. The Existing Controversy of Hormone Replacement Therapy
10. Understanding The Link Between Hormone Replacement and Respiratory Disease
11. Hormone Replacement Therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: